Bifido Obtains Patent Rights for Composition Related to Rheumatoid Arthritis Treatment and Prevention
[Asia Economy Reporter Oh Ju-yeon] Bifido announced on the 13th that it has acquired a patent for a composition containing Bifidobacterium for the improvement, treatment, or prevention of rheumatoid arthritis. The company explained, "Our Bifidobacterium bifidum ATT strain reduces the expression of IL-8, a cytokine overexpressed by arthritis stimulants, back to pre-overexpression levels, demonstrating efficacy in the prevention or treatment of rheumatoid arthritis."
Hot Picks Today
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Exclusive] AI Threatens K-Content... Copyright Infringement Reports Triple in One Year
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.